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Abstract
Background: Seipin is required for the correct assembly of cytoplasmic lipid droplets. In the absence of the yeast
seipin homolog Sei1p (formerly Fld1p), droplets are slow to bud from the endoplasmic reticulum, lack the normal
component of proteins on their surface, are highly heterogeneous in size and shape, often bud into the nucleus,
and promote local proliferation of the endoplasmic reticulum in which they become tangled. But the mechanism
by which seipin catalyzes lipid droplet formation is still uncertain.
Results: Seipin prevents a localized accumulation of phosphatidic acid (PA puncta) at ER-droplet junctions. PA
puncta were detected with three different probes: Opi1p, Spo20p(51–91) and Pah1p. A system of droplet induction
was used to show that PA puncta were not present until droplets were formed; the puncta appeared regardless of
whether droplets consisted of triacylglycerol or steryl ester. Deletion strains were used to demonstrate that a single
phosphatidic acid-producing enzyme is not responsible for the generation of the puncta, and the puncta remain
resistant to overexpression of enzymes that metabolize phosphatidic acid, suggesting that this lipid is trapped in a
latent compartment. Suppression of PA puncta requires the first 14 amino acids of Sei1p (Nterm), a domain that is
also important for initiation of droplet assembly. Consistent with recent evidence that Ldb16p and Sei1p form a
functional unit, the PA puncta phenotype in the ldb16Δ sei1Δ strain was rescued by human seipin. Moreover, PA
puncta in the sei1Δ strain expressing Sei1pΔNterm was suppressed by overexpression of Ldb16p, suggesting a
functional interaction of Nterm with this protein. Overexpression of both Sei1p and Ldb16p, but not Sei1p alone,
is sufficient to cause a large increase in droplet number. However, Ldb16p alone increases triacylglycerol
accumulation in the ldb16Δ sei1Δ background.
Conclusion: We hypothesize that seipin prevents formation of membranes with extreme curvature at endoplasmic
reticulum/droplet junctions that would attract phosphatidic acid. While Ldb16p alone can affect triacylglycerol
accumulation, proper droplet formation requires the collaboration of Sei1p and Ldb16.
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Background
Cytoplasmic lipid droplets, found in most eukaryotic
and some prokaryotic cells, store energy in the form of
neutral lipids, particularly triacylglycerols (TAG) and
steryl esters (SE), which are enwrapped by a single
phospholipid monolayer and associated proteins [1].
They emanate from the endoplasmic reticulum (ER)
and can remain attached there [2]; they also generate
contacts with other organelles, presumably for the pur-
pose of lipid exchange [3, 4].
The synthesis of droplets is becoming better under-
stood. The general view of early steps is that collections
of neutral lipids, as they accumulate between the ER
leaflets after synthesis, eventually will assume a spherical
shape, remaining covered with ER membrane as they
bud outward [5, 6]. However, proteins may control this
reaction [7]. For example, Fit2 is found in the ER, binds
to neutral lipids in isolation, and clearly affects droplet
formation in some systems [8, 9]. Our laboratory has
been focusing on seipin, a protein first identified in se-
vere congenital generalized lipodystrophy, in which adi-
pose tissue fails to develop [10].
Seipin was also identified in yeast screens for morpho-
logically aberrant lipid droplets [11, 12]. The absence of
seipin in yeast leads to both irregularly shaped clusters
of tiny droplets enwrapped in the ER, and “supersized”
droplets; the two forms depends on levels of cell phos-
pholipids, as the supersized phenotype is suppressed by
high levels of the phospholipid precursor, inositol [13].
Droplets in seipin-null cells also frequently bud into the
nucleus, a phenomenon rarely seen in wild type cells
[14]. Moreover, they lack, or have diminished levels, of a
subset of droplet proteins [15, 16].
The absence of seipin also results in slow formation of
droplets under conditions where the amount of total
cellular neutral lipid is identical. When droplets are pro-
duced in this system, they are often actually clusters of
microdroplets with ER fragments attached, as if a prod-
uct of bilayer membrane stability [14]. Overall, these
studies suggest that seipin is important in controlling
the initiation of droplets as well as affecting the size, top-
ology and protein composition of the droplets. How it per-
forms these functions on a molecular basis, however, is
unclear.
Seipin spans the ER membrane twice [17]. Yeast seipin
(Sei1p, formally Fld1p) has two short ends facing the
cytosolic side. We recently reported that the 14 amino
acids comprising the amino-terminal domain (“Nterm”)
was critical for a normal rate of initiation of droplet for-
mation but not for droplet morphology or vectorial
budding (towards the cytoplasm vs. nucleus). However,
while droplets are spherical in the Sei1ΔNterm mutant
(compared to irregularly shaped in sei1Δ), they are larger,
consistent with poor initiation yielding fewer droplets.
Sei1p binds to Ldb16p, and the double deletion is com-
plemented by human seipin [15], suggesting that Sei1p/
Ldb16p is the seipin functional unit.
We now report a novel phenotype of seipin-null cells:
a punctate pattern of phosphatidic acid (PA) in the ER
adjacent or close to droplets. (Note: Independently, an-
other report of PA puncta in seipin-null cells appeared
shortly before submission of this work [18].) These PA
puncta are not present in cells lacking droplets, and they
appear as droplets are formed. Our data are consistent
with the puncta representing aberrant membrane curva-
ture serving as a sink for wedge-shaped lipids, which is
normally avoided or covered by seipin during normal
droplet assembly and maintenance. We further report
that Ldb16p may play a role independent of Sei1p in ac-
cumulation of triacylglycerols.
Results
PA accumulates in puncta in seipin-KO cells
A previous report demonstrated a 20 % increase in
phosphatidic acid (PA) in enriched ER membranes in
seipin-KO (knockout) yeast cells [13]. To confirm this
biochemical finding and determine whether the PA was
associated with an ER subdomain, we tagged Opi1p, a
phosphatidic acid sensor [19], in the genome with GFP
in cells containing or lacking SEI1 (yeast seipin, formerly
FLD1). Under inositol-replete nutrient conditions, Opi1p
is nuclear and represses the synthesis of several genes in
phospholipid biosynthesis. However, during inositol star-
vation, Opi1p traffics to the ER where it binds to PA,
which accumulates there [19]. Wild type cells displayed
weak Opi1p-GFP nuclear fluorescence when cultured in
defined SCD medium (Fig. 1a). However, bright Opi1p-
GFP puncta were observed in 85 % of sei1Δ cells under
the same conditions, suggesting a local accumulation of
PA. An identical phenotype was seen with Opi1p-
mCherry, indicating the pattern was not related to a
specific fluorescent tag (Fig. 1b). The bright Opi1p
puncta in sei1Δ compared with the dim nuclear stain-
ing probably represents a combination of high local
concentration and increase in Opi1p protein – indeed,
cellular Opi1p-mCherry is increased about 80 % of the
sei1Δ strain, for unknown reasons (Fig. 1c).
While membrane PA is a determinant of Opi1p bind-
ing to ER membranes, other factors come into play:
Opi1p also binds to Scs2p in the ER through its FFAT
sequence [20], and the Opi1p-Scs2p complex can bind
to the Yet1p-Yet3p complex [21]. Furthermore, Opi1p
favors PA containing esterified C16 vs. C18 fatty acids
[22]. To rule out Scs2p binding, in the Opi1p puncta, we
tested the effect of a Opi1p FFAT loss-of-function muta-
tion (EEFD200-203ALLA [19]) on the punctate pattern
in sei1Δ and still observed puncta in most cells (Fig. 1d).
We found no difference in Scs2p-GFP localization in
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wild type and sei1Δ strains except a slight increase in
punctate Scs2p-GFP in 10 % of stationary-phase cells cells
(Additional file 1: Figure S1); this cannot account for the
prominent Opi1p puncta. To confirm that the Opi1p
puncta represent concentrated PA, we used another PA
sensor, a fragment of Spo20p (aa 51–91) conjugated to
GFP [23]. In wild type cells the Spo20p fragment bound to
membranes, especially at the cell periphery. However, in
the sei1Δ strain much of Spo20p(51–91)-GFP was also
localized to puncta (Fig. 1e), confirming that PA is highly
localized in the absence of seipin.
Sei1p localizes to ER at the junction of lipid droplets
and is important for initiation of droplet formation and
controlling droplet morphology, in which droplets are
normally uniform in shape and size and are dispersed
along the ER. We hypothesize that the concentrated PA
in the absence of seipin leads to aberrant morphology
observed by three groups: clustered droplets in ER tan-
gles and a large range of sizes [11, 12, 16]. If this is the
case the PA puncta may colocalize with the ER-droplet
aggregates. This was clearly the case, as the puncta
colocalized or were adjacent to both droplets, visualized
with BODIPY 493/503, and were on the ER, detected
with Kar2-CFP-HDEL (Fig. 1f ) or with Sec63-CFP (not
shown). These data suggested that the PA puncta and
aberrant droplets in the absence of seipin were related
phenomena.
We also detected puncta with Pah1p, the phosphatidic
acid phosphatase that is the ortholog to mammalian
lipin [24]. Most of Pah1p is cytosolic. However, more of
it can be driven to ER membranes by overexpression of
the DAG kinase, Dgk1p, presumably by an increase in
phosphatidic acid, the product of Dgk1p [25]. Pah1p
puncta also has been demonstrated very recently by new
lipid droplets [26]. While membrane localization of
Pah1p-GFP in living sei1Δ cells was not apparent in our
hands, strong puncta occur in cells fixed with 2 % (v/v)
formaldehyde (Fig. 2a); the strong puncta was not a re-
sult of higher expression of Pah1p in sei1Δ, as it was






Fig 1 Phosphatidic acid (PA) is concentrated in nuclear ER and lipid droplets in sei1Δ. a Opi1-GFP localization in wild type and in sei1Δ cells. Left,
merged fluorescent and brightfield images are shown; equivalent intensity settings. Inset: contrast is enhanced in the area enclosed in dashed
rectangle to more clearly show nuclear staining of Opi1-GFP in wild type cells. Right, percentage of cells with punctate staining. Average ± SE
from three experiments, > 90 cells counted in each. b As in (A) but with Opi1-mCherry in W303 strain. c Immunoblot of Opi1-mCherry in wild
type and sei1Δ cells, representative of three experiments. Signals were quantified using an Infrared detection system (Odyssey LiCoR Scanner),
which showed that the Opi1-mCh signal was higher than that of wt (1.8 ± 0.2 fold). The cytoplasmic marker Zwf1p is used as a control. d Mutation of
the FFAT motif in the chromosomal copy of Opi1-GFP reduces but does not eliminate the PA puncta. Left, GFP fluorescence; right, quantification of
the percentage of cells with puncta. e Fluorescence microscopy of wild type and sei1Δ cells (W303 background) expressing GFP-Spo20(51–91). As in
(A) but with GFP-Spo20(51–91). f Cells co-expressing Opi1-mCherry and Kar2-CFP-HDEL (ER marker) were stained with BODIPY 493/503. In the first
merged images (fourth column), the BODIPY channel is green, Opi1-mCherry red, and Kar2-CFP-HDEL blue. The second merged images (fifth column)
are magnifications of the preceding white boxes, illustrating Kar2 (ER, blue) and Opi1 (red). Scale bars, 5 μm., and all micrographs correspond to single
optical sections. For quantification of cells with PA-puncta, at least 90 cells were counted in each of at least three independent experiments




Fig. 2 Pah1p also forms puncta in sei1Δ cells. a Chromosomally tagged Pah1p with GFP (Pah1-GFP) in wt and sei1Δ cells (BY4741 background).
Puncta were apparent in sei1Δ when cells were fixed with 2 % formaldehyde solution but not in living cells. b Pah1p-FLAG was expressed similarly in
wt and sei1Δ cells (W303 background). Lanes 1–3 mid-log cells; lanes 4–6 stationary phase cells. Lanes 1,4 wt; lanes 2,5 FLAG knock-in behind PAH1
ORF in wt; lanes 3,6 FLAG knock-in behind PAH1 ORF in sei1Δ cells. Whole cell lysates were immunoblotted with anti-FLAG and anti-Zwf1p and imaged
by infrared fluorescence detection method (Odyssey™ Western blots). Asterisks, non-specific bands. c Catalytically-dead Pah1p forms dots that
colocalize with Opi1p-puncta. Wild-type or sei1Δ cells, both containing the Opi1-mCherry allele were transformed with plasmid encoding Pah1p(D398A
D400A)-GFP. Living cells were imaged, illustrating colocalized markers (Opi1p-mCh and Pah1(D398A D400A)-GFP colored red and green, respectively,
in the merged images). d Dots of Pah1p(D398A D400A)-GFP in sei1Δ Opi1-mCherry recover slowly after photobleaching. After bleaching the indicated
punctum with laser, recovery is slow, as shown by time-lapse (10 s interval). e Quantification of fluorescence recovery. The intensities were normalized
to the initial intensity of the each puncta before bleaching. Data represent 5 bleaching experiments, mean ± SEM
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(Fig. 2b). The fixative may have trapped the enzyme on
the membrane, perhaps by not allowing it to metabolize
the PA to which it is bound. To determine whether these
spots represent PA puncta, we used a catalytically dead
mutant, Pah1-D398A/D400A-GFP [25]. This protein
clearly localizes to puncta in living cells, and the spots co-
localize to Opi1p-mCherry (Fig. 2c). Thus, Pah1-D398A/
D400A-GFP appears to be another PA sensor, albeit not
as sensitive as Opi1p. A fluorescence bleaching-recovery
experiment indicated that there was only slow (plateau
after ~ 50 s) and incomplete replacement of bleached
Pah1-D398A/D400A-GFP, suggesting that the PA pool in
the puncta is relatively stable (Fig. 2d and e).
The PA puncta appear during lipid droplet formation
We then asked whether the appearance of PA puncta,
which were generally adjacent to droplets on the ER in
sei1Δ cells, required droplets. This was tested in strains
that are deleted in all but one enzyme that synthesizes
neutral lipids for droplets, and in which the expression of
the remaining enzyme is under control of the galactose
promoter [14, 27]. Two such strains were utilized in which
TAG or SE droplets form subsequent to induction of
DGA1 or ARE1, respectively, in galactose-containing
medium. The endogenous copy of OPI1 was tagged in
these strains with mCherry to allow detection of PA
puncta. No PA puncta were observed in cells containing
SEI1 when DGA1 was induced, as expected (Fig. 3a).
Puncta were also absent in cells also deleted in SEI1 when
growing in glucose. However, upon induction of DGA1,
PA puncta were observed as droplets appeared (at 3 h). At
this time point there were many droplets without clear
puncta, although each punctum overlapped or was adja-
cent to droplets, suggesting that droplet formation in the
absence of seipin may precede and even cause develop-
ment of puncta.
We considered that the PA puncta in sei1Δ cells were
related to TAG synthesis by Dga1p, as PA is a precursor
of TAG. This was not the case. If droplet formation
was driven instead by the steryl acetyltransferase Are1p,
resulting in steryl ester formation and very little TAG,
we saw the identical behavior: bright PA puncta upon
formation of new droplets (Fig. 3b). PA puncta, there-
fore, form in seipin-null cells as droplets form regard-
less of the neutral lipid or synthetic enzyme producing
them.
A B
Fig. 3 PA puncta appear with TAG and SE droplets in sei1Δ strains. Yeast strains chromosomally expressing Opi1-mCherry, with or without a SEI1
allele, and which only produce neutral lipid upon addition of galactose ((a) 3KO(GALDGA1) produces TAG, while (b) 3KO(GALARE1) produces steryl
ester, SE [14]), were subjected to galactose at 0 time and monitored every three hours. PA puncta (marked by Opi1-mCherry) became apparent
only in sei1Δ cells and only upon formation of lipid droplets, detected by BODIPY. PA puncta were present in both TAG and SE droplets
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No single enzyme in PA metabolism is responsible for the
PA puncta
We attempted to identify an enzyme related to PA that
was responsible for either the synthesis of the PA in the
puncta or their absence in the presence of Sei1p (Fig. 4a).
PA can be generated from glycerol-6-phosphate (G-3-P)
by acyltransferases in two steps: first to lysophosphatidic
acid (LPA) by Gpt2p, then to PA by Loa1p, Ale1p, or
Slc1p. PA can also be generated from phosphatidyl cho-
line by the phospholipase D, Spo14p, or from diacylglyc-
erol (DAG) by the DAG kinase Dgk1p. We deleted each
of these enzymes in strains containing mCherry-tagged
Opi1p with or without SEI1. As expected, there were no
PA puncta in the strains containing SEI1 (Fig. 4b). Con-
versely, all strains in the sei1Δ contained puncta, ruling
out the possibility that one PA synthetic enzyme was
uniquely responsible for them.
We also attempted to eliminate the puncta by overex-
pressing enzymes that metabolized PA. However, high
expression of Pah1p (which converts PA to DAG) or
Cds1p (which converts PA to CDP-DAG) failed to attenu-
ate the Opi1-mCherry puncta in the sei1Δ strain (Fig. 4c),
suggesting that the puncta are not a result of suppression
of these enzymes in the absence of seipin, and also that
these enzymes do not have good access to the puncta. To
attempt to target these two enzymes to the PA puncta, we
generated fusion proteins between Cds1p or Pah1p and
Sei1ΔNterm (Sei1p missing the first 14 amino acids, which
partially targets to ER-droplet junctions [14] but does not
suppress PA puncta; see below). The Cds1p-Sei1ΔNterm
fusion had no effect on the PA puncta (data not shown),
while the cells expressing Pah1p- Sei1ΔNterm were largely
dead and were not further analyzed.
Formation of supersized droplets that accumulate in
sei1Δ cells can be suppressed by addition of 75 μM in-
ositol to the medium, which results in an increase in
phospholipid synthesis [13]. We found that suppression
of supersized droplets by inositol addition did not inhibit
the accumulation of PA puncta in sei1Δ cells (Additional
file 1: Figure S2).
Fig. 4 Manipulation of single metabolic enzymes do not eliminate PA puncta. a Diagram of pathways leading to PA production and use. b, c
Genetic manipulations were performed in wt and sei1Δ strains, each expressing mCherry behind OPI1 ORF in the chromosome. b The indicated
(at left) enzymes producing PA were knocked out. All resulting strains still produced PA puncta. c The two enzymes that metabolize PA, Pah1p
and Cds1p, were overexpressed on plasmids using the PGK1 promoter. Neither resulting strain attenuated the PA puncta. Scale bars, 5 μm
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In summary, none of our genetic manipulations of sin-
gle genes to lower PA levels eliminated the puncta, sug-
gesting that PA from multiple sources was trapped
there, and that it was not easily accessible as substrate to
enzymes for further metabolism.
PA puncta disappear in the presence of human seipin or
a combination of Sei1pΔNterm and Ldb16p
Recently Ldb16p was identified as a binding partner for
Sei1p [15]. Knocking out LDB16 produced a droplet
phenotype similar to sei1Δ. The double knockout could be
rescued by human seipin, suggesting that Sei1p-Ldb16
formed a functional seipin complex [15]. Consistent with
this report we also observed similar droplet phenotypes of
sei1Δ and ldb16Δ, namely a combination of droplet clus-
ters (diffuse BODIPY pattern) and supersized droplets
(Fig. 5a); we detected no droplet morphological difference
between these two strains. Interestingly, in a strain in
which both genes were deleted (“ΔΔ”), we observed sig-
nificantly more cells with supersized droplets (Fig. 5b),
suggesting that the frequent droplet clusters observed in
the single knockouts may be a gain-of-function phenotype
of expression of one of the partners alone. Expression of
both proteins in the strain under the strong PGK1
promoter resulted in a different phenotype: a proliferation
of very small droplets (too many to count) dispersed
throughout the cytoplasm (Fig. 5a). Yeast Sei1p has been
shown to be important for initiation of droplet assembly
[14]. This experiment suggests there are no other limiting
factors for droplet production other than Sei1p and
Ldb16p.
We recently showed that removal of the amino terminal
14 amino acids from seipin (generating Sei1ΔNterm) re-
sulted in a partial phenotype compared to the null strain:
droplet initiation was slower, resulting in larger droplets,
but the droplets appeared otherwise normal [14]. Simi-
larly, overexpression of Sei1ΔNterm with Ldb16p in the
double deletion strain resulted in a homogeneous popula-
tion of droplets larger than found in the full-length Sei1p
control (Fig. 5a).
PA puncta were observed in the ΔΔ strain (Fig. 5c). Re-
placement of either protein alone did not result in their
disappearance. However, no puncta were observed upon
expression of human seipin (BSCL2). As human seipin
can complement yeast seipin null strains (sei1Δ and
sei1Δ ldb16Δ) in promoting droplet formation [15], our
data suggest that preventing PA puncta is a conserved
role of seipin.
Sei1ΔNterm, even when overexpressed, was unable to
cause the disappearance of PA puncta in the sei1 null
strain (Fig. 5d), and caused the appearance of PA puncta
even when expressed in the wild type strain (not shown);
this dominant negative effect was seen before in regards
to droplet morphology [14]. Surprisingly, PA puncta were
suppressed when Sei1ΔNterm was co-overexpressed with
Ldb16, either as independent proteins or as a tethered
unit, Ldb16- Sei1ΔNterm (Fig. 5e). Therefore, while the two
proteins together produce larger droplets (consistent with
the role of the Sei1p amino terminal domain in droplet
initiation), this phenotype can be dissected away from the
appearance or PA puncta.
In our system, deleting SEI1, LDB16, or both resulted
in a strong decrease in cellular TAG with no effect of SE
levels (Fig. 5f and data not shown). Replacement with
overexpressed Sei1p or Sei1pΔNerm in the double dele-
tion mutant did not increase TAG. However, overexpres-
sion of Ldb16p alone in the double deletion strain
restored TAG to normal levels. This result indicates that
Ldb16 can function independently of Sei1p to affect
droplet size and TAG accumulation.
Discussion
In this report we show a strong and localized accumula-
tion of PA in ER membranes of cells that lack seipin. PA
accumulation only occurred in cells with droplets and
seemed to occur concomitant or shortly after droplet
formation. We could find no single enzyme that pro-
duces PA to account for the localized puncta, nor an
overexpressed enzyme that normally utilizes PA to make
the puncta disappear (although we cannot rule out that
Opi1p is sequestering the PA from metabolic enzymes).
The study of strains with multiple knockouts in PA-
related pathways is likely to provide more information.
Nevertheless, based on our experiments thus far, we
conclude that the puncta likely represents a sink of PA
that is unavailable to utilizing enzymes.
PA is a wedge-shaped molecule that would be expected
to intercalate into curved membranes. Our data are con-
sistent with a model in which the radical curvature that
accompanies droplet budding will trap wedge-shaped mol-
ecules such as phosphatidic acid. As phosphatidic acid is
at the nexus of phospholipid and neutral lipid synthesis,
and the ER is home to many enzymes in these pathways,
the flux through PA in the ER should be high, allowing for
trapping of this metabolic intermediate (Fig. 6, right).
Changes in metabolic fluxes may also affect the intensity
of the puncta, but our data suggest that such fluxes are
not responsible for the puncta themselves.
Seipin may prevent PA trapping by providing the curva-
ture itself, thereby blocking the insertion of PA (Fig. 6,
left). Such a role would be consistent with its function in
initiating droplet formation [14] as the seipin-induced
curvature could facilitate the entry of neutral lipids into a
nascent bud. Seipin also could be acting more indirectly:
By facilitating droplet formation, it may orchestrate a
more gentle process by which spontaneous blebbing of
lipid drops is avoided which may be accompanied by
more severe bilayer curvature at trapping of PA. Necks




Fig 5 Sei1ΔNterm suppresses puncta but only in the presence of overexpressed Ldb16p. a BODIPY staining of droplets in the indicated yeast
strains. The multiple and less distinct droplets in the ΔΔ + Sei1p + Ldb16p strain is shown in greater magnification at the bottom. b Quantification
of cells with supersized (>1 μm diameter) droplets in the indicated strains. Three fields of >240 cells/field were counted from two independent
experiments. Error bars signify SEM. Lines above the bars indicate statistical difference between the indicated pairs, based on the Turkey range
test in conjunction with ANOVA. *, p < 0.05; **, p <0.01. c Human seipin (BSCL2) suppresses PA-puncta in the ΔΔ strain. d PA-puncta in sei1Δ
Opi1-GFP (BY4742) are not suppressed by Sei1ΔNterm-mCherry. An overexpressed mCherry fusion was used to illustrate the correct ER targeting.
e Puncta are absent with the combination of Sei1ΔNterm and Ldb16. Green, BODIPY493/503; red, Opi1-mCherry. f Overexpressed Ldb16 in the ΔΔ
background increases TAG but not SE levels. TAG and SE in the W303 wild type control strain set at 100 %. Bars and error bars represent mean +
range from two independent experiments. Lines above the bars indicate statistical difference between the indicated pairs, based on the Turkey
range test in conjunction with ANOVA. **, p <0.01; ***, p < 0.001. Scale bars, 5 μm
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the ER-droplet junctions have been observed in which
the curvature is gentle [28].
It is interesting that overexpressing both Sei1p and
Ldb16p results in many more lipid droplets than wild
type (Fig. 5a). Overexpressing Sei1p alone does not re-
sult in more droplets, which was concerning if seipin
played a role in droplet initiation [12]. The large increase
in droplet number upon overexpression of both proteins
is consistent with these two subunits being sufficient for
droplet formation with no other proteins required in
stoichiometric amounts.
In our studies deletion of either SEI1, LBD16 or both
resulted in a 50-60 % decrease in TAG accumulation
(Fig. 5f ). This is contradictory to an earlier report show-
ing an increase in TAG in the absence of SEI1 [11].
Moreover, several reports have shown a tissue-specific
decrease in TAG with seipin overexpression [29]. In our
hands we find that the decrease in TAG is more severe
in defined medium (as used here) compared to rich YPD
broth. Although a decrease in TAG in the null strain is
consistent with the lipodystrophy phenotype in patients
[10], it is difficult to relate effects on adipogenesis in the
mammalian system with effects seen here in yeast.
Nevertheless, it is interesting that the decrease in TAG
in the ΔΔ strain is suppressed in the presence of overex-
pressed Ldb16p. This protein was shown to be unstable
in the absence of Sei1p [15]. Our result indicates that
enough protein remains upon overexpression to signifi-
cantly increase TAG accumulation. Ldb16p may have
this effect by directly influencing TAG synthesis (by acti-
vating Dga1p or Lro1p) or by increasing the rate of lip-
olysis or lipophagy. While Ldb16p in the ΔΔ strain
suppressed the decrease in TAG, it did not suppress PA
puncta formation, indicating that the two phenomena
are not linked. Regardless of mechanism, it is the first
observation that Ldb16 functions in lipid storage inde-
pendent of its binding partner, and it is consistent with
the observation that a subpopulation of Ldb16p does
not colocalize with Sei1p [15].
The functions of seipin can be dissected by the elimin-
ation of the first fourteen amino acids of Sei1p: the small
clusters of droplets enwrapped in ER that are found in
sei1Δ null cells are not formed, and frequent droplets in
the nucleus are also avoided. Initiation of droplet assem-
bly is still sluggish however, which is consistent with
larger and fewer droplets in cells [14]. We tethered
Ldb16p to Sei1ΔNterm to determine if the defect in the
truncated form may be related to its ability to bind prop-
erly to Ldb16p, although previous data showed that the
transmembrane and loop regions of Sei1p were import-
ant for pull down of the two proteins [15]. Indeed, cells
expressing the tethered form lacked PA puncta (Fig. 5).
However, droplets were still larger than normal in the
strain, suggesting the tethered proteins could not restore
a normal rate of droplet initiation. The phenotype was
similar if the two proteins were singly expressed. These
results suggest that avoiding PA puncta is not sufficient
for seipin to generate wild type droplets. It is possible
that Ldb16p-Sei1pΔNterm can deform the membrane suf-
ficiently to avoid trapping PA but not to the extent re-
quired for a normal rate of droplet initiation.
In summary, we have shown the presence of PA puncta
in seipin null cells and suggest that these are caused by
extreme curvature of the membrane, attracting wedge-
shaped lipids such as PA. Puncta are not formed until
droplets appear, and the puncta are formed regardless of
neutral lipid types that comprise the core. Our data using
overexpressed Ldb16p shows its ability to suppress the PA
puncta produced by Sei1pΔNterm and that it can regulate
TAG levels independent of Sei1p.
Conclusions
The functional seipin complex in yeast is comprised of
Sei1p and Ldb16p. Seipin is shown here to prevent the
Fig. 6 Working model for PA puncta in seipin-deleted cells. ER-droplet interface is shown. Left, normally, PA fluxes from generating to metabolizing
enzymes. PA flux through the TAG pathway into droplets is not specifically shown. Curvature at the junction is mild or it protected by seipin. Right, in
the absence of seipin, some PA is trapped at the ER-drop interface in regions of high curvature, creating punta seen by fluorescence probes
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localized accumulation of phosphatidic acid in the ER
adjacent to development of lipid droplets. The accumu-
lation only occurs with droplet formation and occurs for
both triacylglycerol (TAG) and steryl ester (SE) droplets.
Sei1p lacking its amino terminus is not sufficient to
prevent droplet formation, but this defect can be sup-
pressed by overexpressing Ldb16p. Lack of either Sei1p
or Ldb16p strongly inhibits the accumulation of TAG
but not SE in cells. However, overexpression of Ldb16p
in the absence of Sei1p causes restoration of TAG levels,
Table 1 A list of strains used in this study
Strain Name Genotype or Description Ref/Source
BY4741- or 4742-based strains Mata (BY4741) or Matα (BY4742) his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 Open Biosystems
Opi1-GFP Opi1-GFP::HIS3 (BY4742), a haploid progeny from crossing
BY4741 Opi1-GFP::HIS3 and BY4742 sei1Δ::Kan
Open Biosystems
Scs2-GFP Scs2-GFP::HIS (BY4742) Open Biosystems
sei1Δ sei1Δ::KanMX (BY4742) Open Biosystems
sei1ΔOpi1-GFP Opi1-GFP sei1Δ::KanMX (BY4742), a haploid progeny from
crossing Opi1-GFP::HIS3 (BY4741) and sei1Δ::Kan (BY4742)
This study
sei1ΔScs2-GFP Scs2-GFP sei1Δ::KanMX (BY4742), a haploid progeny from
crossing Scs2-GFP::HIS3 (BY4741) and sei1Δ::Kan (BY4742)
This study
Opi1FFATmut-GFP Opi1FFATmut-GFP::KanMX6 (BY4742) This study
sei1Δ Opi1FFATmut-GFP Opi1FFATmut-GFP::KanMX6 (BY4742), a crossed progeny
between Opi1FFATmut-GFP and sei1Δ ::Kan (BY4741)
This study
Pah1-GFP::HIS3 Pah1-GFP::HIS3 (BY4741) Open Biosystems
sei1Δ Pah1-GFP sei1Δ::Hph Pah1-GFP::HIS3 (BY4741) This study
W303-based strains MATa (W303-1A) or MATα (W303-1B), leu2-3,112 trp1-1
can1-100 ura3- 1 ade2-1 his3-11,15
Thomas 1989 [35], Open Biosystems
Opi1-mCherry Opi1-mCherry::KanMX (W303-1A or 1B) This study
sei1Δ sei1Δ::Hph (W303-1B) This study
sei1Δ Opi1-mCherry sei1Δ::Hph Opi1-mCherry (W303-1B) This study
Pah1-3xFlag Pah1-3xFlag::KanMX (W303-1A) This study
sei1Δ Pah-3xFlag sei1Δ::Hph Pah1-3xFlag::KanMX (W303-1A) This study
3KO(GalDGA1) Opi1-mCherry 3KO(GalDGA1) Opi1-mCherry::KanMX Cartwright et al., 2015 [14]; this study
3KO(GalDGA1) sei1Δ Opi1-mCherry 3KO(GalDGA1) sei1Δ Opi1-mCherry::KanMX Cartwright et al., 2015 [14]; this study
3KO(GalARE1) Opi1-mCherry 3KO(GalARE1) Opi1-mCherry::KanMX Cartwright et al. 2015 [14]; this study
3KO(GalARE1) sei1Δ Opi1-mCherry 3KO(GalARE1) sei1Δ Opi1-mCherry::KanMX Cartwright et al., 2015 [14]; this study
gpt2Δ Opi1-mCherry gpt2Δ::NAT Opi1-mCherry ::KanMX This study
gpt2Δ sei1Δ Opi1-mCherry gpt2Δ::NAT sei1Δ::Hph Opi1-mCherry ::KanMX This study
slc1Δ Opi1-mCherry slc1Δ::NAT Opi1-mCherry ::KanMX This study
slc1Δ sei1Δ Opi1-mCherry slc1Δ::NAT sei1Δ::Hph Opi1-mCherry ::KanMX This study
ale1Δ Opi1-mCherry ale1Δ::NAT Opi1-mCherry ::KanMX This study
ale1Δ sei1Δ Opi1-mCherry ale1Δ::NAT sei1Δ::Hph Opi1-mCherry ::KanMX This study
loa1Δ Opi1-mCherry loa1Δ::NAT Opi1-mCherry ::KanMX This study
loa1Δ sei1Δ Opi1-mCherry loa1Δ::NAT sei1::Hph Opi1-mCherry ::KanMX This study
dgk1Δ Opi1-mCherry dgk1Δ::NAT Opi1-mCherry ::KanMX This study
dgk1Δ sei1Δ Opi1-mCherry dgk1Δ::NAT sei1Δ::Hph opi1::Opi1-mCherry KAN This study
spo14Δ Opi1-mCherry spo14Δ::NAT Opi1-mCherry ::KanMX This study
spo14Δ sei1Δ Opi1-mCherry spo14Δ::NAT sei1Δ::Hph Opi1-mCherry ::KanMX This study
ldb16Δ ldb16Δ::Nat This study
sei1Δ ldb16Δ (”ΔΔ”) sei1Δ::Hph ldb16Δ::Nat This study
ldb16Δ Opi1-mCherry ldb16Δ::Nat Opi1-mCherry::Kan This study
sei1Δldb16ΔOpi1-mCherry sei1Δ::Hph ldb16Δ::Nat Opi1-mCherry::Kan This study
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suggesting an independent role of Ldb16p in controlling
TAG concentration.
Methods
Cell strains and cell culture conditions
All yeast strains are based on either BY4742 or the
W303-1A haploid cells except when indicated. See
Table 1 for strains used. Knock-out or knock-in strains
were generated by standard procedures [30]. Drug re-
sistance cassettes conferring resistance to hygromycin
B (Hph) and nourseothricin (Nat) [31] were kindly pro-
vided by Benjamin Tu (UT Southwestern). SCD-based
defined media ([14] with 2 % dextrose) with appropriate
supplements for auxotrophies were used for all experi-
ments, except for the experiment shown in Fig. 3,
where lipid droplets were induced with galactose [14].
For W303 strain, additional adenine (800 ug/mL) was
added to suppress the ade (red) phenotype for fluores-
cence studies. For log phase and stationary phase, cells
were grown for 6 to 8 h, and 16 to 24 h, respectively
after back-dilution.
Reagents
Nourseothricin was purchased from Werner Bioagents
(Jena Germany). Hygromycin B was purchased from
Gold Biotechnology (Goldbio.com, St. Louis, MO). G418
Sulfate (used to select for resistance to the KanR gene)
was purchased from AG Scientific (San Diego, CA).
Plasmids
Plasmid GFP-Spo20 (51–91) was a gift of Aaron Neiman
(Stony Brook University). Plasmids encoding Pah1-GFP
and Pah1-D398A/D400A-GFP were kindly provided by
Symeon Siniossoglou (University of Cambridge). A TAP
tag used in this study was derived form the sequence of
HBH TAP tag followed by the KanMX6 marker from
plasmid DQ407918 (PK440; pFA6a-HBH-KanMX6 [32],
a gift from Anne Spang (Biozentrum, Basel) such that
the HBH TAP tag was placed at the carboxy end of the
modified protein. The pFA6a mCherry-KanMX6 plasmid
was a gift of Chuck Cole (Dartmouth U., Dartmouth,
NH). Other plasmids used in this study were summa-
rized in Table 2.
Table 2 A list of plasmids used in this study
Plasmids Description Ref/source
pRS426 GFP-Spo20(51–91) pRS426 expressing GFP fused to Spo20(51–91) which is sensing PA Nakanishi et al., 2004 [23]
YCpLac111-Pah1-GFP PAH1-GFP under control of the PAH1 promoter into CEN/LEU2 vector Karanasios et al., 2010 [25]
YCpLac111-Pah1-D398AD400A-GFP PAH1[D398A D400A]-GFP under control of the PAH1 promoter into
CEN/LEU2 vector
Karanasios et al., 2010 [2])
pRS315 PGK1 Yeast centromeric expressing plasmid (YCp) with LEU2 marker carrying
PGK1 promoter/ terminator
Binns et al., 2006 [36]
pRS315 PGK1-CFP-HDEL pRS315 expressing ER luminal CFP marker Szymanski et al., 2007 [12]
pRS315 PGK1-Pah1 pRS315 expressing Pah1 under control of PGK1 promoter/terminator Adeyo et al., 2011 [37], This study
pRS 315 PGK1-Cds1 pRS315 expressing Cds1 under control of PGK1 promoter/terminator This study
pRS 315 PGK1-Dgk1 pRS 315 expressing Dgk1 under control of PGK1 promoter/terminator This study
pRS315 PGK1-mCherry pRS315 expressing mCherry under control of PGK1 promoter/terminator Cartwright et al., 2015 [14]
pRS315 PGK1-Sei1-mCherry pRS315 expressing Sei1-mCherry under control of PGK1 promoter/terminator Cartwright et al., 2015 [14]
pRS-315 Sei1ΔNterm-mCherry pRS315 expressing Sei1ΔNterm-mCherry under control of PGK1
promoter/terminator
Cartwright et al., 2015 [14]
pRS315 PGK1-Ldb16 pRS315 expressing Ldb16 under control of PGK1 promoter/terminator This study
pRS315 PGK1-Sei1 pRS315 expressing Sei1 under control of PGK1 promoter/terminator Szymanski et al., 2007 [12]
pRS315-BSCL2 pRS315 expressing BSCL2 (short isoform) under control of PGK1
promoter/terminator
Szymanski et al., 2007 [12]
pRS316 PGK1-Sei1-TAP pRS316 expressing SEI1-TAP fusion protein under control of PGK1
promter/terminator. TAP sequence was amplified from HBH TAP tag
(HBH-KanMX6), a gift from Anne Spang (Biozentrum,Basel)
Tagwerker et al., 2006, This study
pRS316 PGK1-Sei1ΔNterm -TAP pRS316 expressing SEI1ΔNterm -TAP fusion protein under control of PGK1
promter/terminator.
This study
pRS316 PGK1-Ldb16-Sei1-TAP pRS316 expressing Ldb16-Sei1-TAP fusion protein under control of PGK1
promter/terminator. TAP seq was generated similar way to the above.
This study
pRS316 PGK1-Ldb16-Sei1ΔNterm -TAP pRS316 expressing Ldb16-Sei1ΔNterm -TAP fusion protein under control of
PGK1 promter/terminator. TAP seq was generated similar way to the above.
This study
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Immunoblot
For examining protein expression, whole lysates were
prepared in SUME BUFFER (1 % SDS, 8 M Urea,
10 mM MOPS, pH 6.8, 10 mM EDTA, 0.01 % bromo-
phenol blue) from yeast as described [33] and subjected
to SDS-PAGE followed by immunoblot. mCherry and
FLAG epitope were probed with rabbit polyclonal anti-
DsRed (Clontech, 632496) and mouse monoclonal anti-
FLAG M2 (Sigma-Aldrich, F3165) antibody, respectively.
Rabbit Anti-glucose-6-phosphate dehydrogenase (Zwf1p)
antibody (Sigma, A9521) was used for a loading control.
Antibodies were detected using infrared-dye conjugated
secondary antibodies and LICOR Odyssey detection
system.
Fluorescence microscopy
All microscopy except for the FRAP experiment (Fig. 2d
and e) was performed on a Zeiss Axioplan 2E micro-
scope and images were acquired into Slidebook 4.2 or
5.0 (Intelligent Imaging Innovations, Denver, CO) with a
SensiCam digital camera (Cooke), as previously de-
scribed [14]. All images represent single optical planes
(approximately halfway through the cell) except for
those shown in Fig. 5, which are maximal projection im-
ages from a z-stack of ~15 planes spaced 0.3 μ apart. For
lipids droplet staining, BODIPY 493/503 was used. To
fix the yeast cells, 2 % formaldehyde was used as de-
scribed before [34].
FRAP experiment
FRAP experiments were performed on a laser scanning
confocal spectral microscope (Zeiss LSM510 Meta) using
a 63x oil immersion oil (NA1.4) at room temperature.
Cells were put on 2.5 % agarose pads in SC-leu media cov-
ered on glass slide as described (ref). GFP fluorescence
was detected using the 488 laser line of an Argon laser in
conjunction with a BP 500–530 filter.
A defined region of interest (ROI, 0.9 μm in diameter)
was photobleached at full laser power at 488 nm (100 %
power, 25 iterations) and recovery of fluorescence was
monitored by scanning the ROI at low laser power (5 %
of laser power) by 10-s interval scans under 4x zoom.
Fluorescence intensity was normalized to the prebleach
intensity. Images intensity were measured using Image J
(v.1.41, NIH).
Lipid analysis
Lipid extraction and one-dimensional thin layer chroma-
tography were performed as previously described [14].
Lipid bands were digitally scanned and their intensities
were determined by ImageJ. Concentrations were calcu-
lated relative to serial dilutions of lipid standards.
Statistical analyses
Prism v. 6 (GraphPad, La Jolla, CA) was used for all stat-
istical analysis. For experiments with multiple groups,
one-way ANOVA and the Tukey test were used to deter-
mine the degree of significance between samples.
Availability of supporting data
Additional file 1: Figures S1 and S2 accompany the
manuscript.
Additional file 1: Figure S1: Scs2p-GFP can form
strong puncta in sei1Δ cells, demonstrates puncta of this
fluorescent hybrid especially in stationary phase.
Additional file 1: Figure S2: Suppressing supersized
droplets with inositol does not inhibit PA puncta forma-
tion, using Opi1-mCherry to demonstrate PA puncta.
All supporting data can be found in the manuscript text
and its additional files.
Additional file
Additional file 1: Figure S1. Scs2p-GFP can form strong puncta in sei1Δ
cells. Shown are GFP fluorescence images in log or stationary phase cells.
Scale bar, 5 μm. Figure S2. Suppressing supersized droplets with inositol
does not inhibit PA puncta formation. (A) WT or (B) sei1Δ cells (both ex-
pressing Opi1-mCherry) were grown in SCD ± 75 μM inositol for 6 h. The
added inositol suppressed supersized droplets in sei1Δ but not PA puncta.
Scale bars, 5 μm. (PDF 2388 kb)
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